NEWS OUT! Sterling Consolidated Issues a Definitive Term

New Post Public Reply Private Reply Replies (1) Message Board
KaiserSose
NEWS OUT! ✪✪ Sterling Consolidated Issues a Definitive Term Sheet ✪✪

Company Issued Term Sheet to Large, Regional Distributor With Revenues Over $2 Million

http://finance.yahoo.com/news/sterling-consol...00265.html

NEPTUNE, N.J., May 7, 2014 (GLOBE NEWSWIRE) -- Sterling Consolidated Corp. (STCC) (the "Company" , a leading supplier of hydraulic and pneumatic seals to the automotive and industrial marketplace, today announced that its Acquisition Committee has issued a term sheet to a NJ distributor with annual revenues of more than $2 million. This target company is profitable and well-established in the marketplace with a rich 50-year history and includes a highly skilled engineering department.

This potential acquisition carries much synergy to the Company's business model, and would allow the Company to consolidate occupancy and operations with Sterling's headquarters in Neptune, New Jersey. In addition to new domestic and international customers, the synergies would provide significant operational cost savings. Sterling's management is currently negotiating with the target company to finalize the basic terms of the Agreement.

Darren DeRosa, Chief Executive Officer of Sterling Consolidated, commented, "Our Acquisition Committee continues to negotiate with the most likely candidates for acquisition. We continue to monitor cash flow and use current proceeds of recent financings to complete our acquisitions."

The estimated closing date is September 15, 2014.

Sterling Consolidated Corp. (STCC) Stock Research Links

STCC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

BIC's Latest Voting Rights and Shares Disclosure Details

Updated Category News Views 180

Key Disclosure on Voting Rights and Shares As a reputable leader in stationery and consumer products, BIC is committed to transparency. Recently, they provided crucial insights into their corporate structure, particularly regarding the total number of voting rights and shares. This disclosure highlights the ongoing dedication towards maintaining clear communication with...

Continue Reading
AGCO Showcase: Innovations and Autonomy for 2026 Farmers

Updated Category News Views 212

AGCO (NYSE: AGCO) is strutting its stuff at the 2026 Commodity Classic in San Antonio from February 25-27. Picture this: over 24,000 square feet jam-packed with cutting-edge agricultural machinery aimed at farmers who want to boost their operations. Yeah, the buzz is all about showcasing their big guns like Fendt®, Massey Ferguson®, and PTx™—but dig deeper into...

Continue Reading
Revolutionizing Healthcare Marketing with Ignite Pulse Solutions

Updated Category News Views 371

Revolutionizing Healthcare Marketing with Ignite Pulse Solutions In the shifting landscape of healthcare marketing, WebMD Ignite introduces a significant enhancement aimed at assisting health systems in thriving amidst the challenges posed by AI and budget constraints. Presenting Ignite Pulse™, this groundbreaking solution offers a comprehensive growth strategy designed...

Continue Reading
Eupraxia Pharmaceuticals Welcomes New Leaders to Innovate Growth

Updated Category News Views 190

Eupraxia Pharmaceuticals Expands Leadership Team Eupraxia Pharmaceuticals Inc. (TSX: EPRX) (NASDAQ: EPRX), known for its innovative approaches in drug delivery technology, has recently announced two significant additions to its leadership. Dr. Amanda Malone has been appointed as the Chief Operating and Scientific Officer, alongside Dr. Rahul Sarugaser as Executive Vice...

Continue Reading
Illumina Enhances Oncology Solutions for Better Cancer Care

Updated Category News Views 186

Illumina's Latest Developments in Oncology In an exciting development, Illumina Inc. (NASDAQ: ILMN) has announced a significant expansion in its clinical oncology portfolio. This move aims to set a new standard of care and enhance access to precision therapies through advanced genomic profiling. Following the recent FDA approval of Illumina's TSO Comprehensive test, the...

Continue Reading